Here, we show a novel function of MMF/MPA, i.e., the ability to inhibit IFN-α production by human pDCs upon cellular activation with SLE serum or CpG-ODN via inhibiting the nuclear translocation of IRF7. This evidence concerns the gene IFNA1 and systemic lupus erythematosus.